A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-56Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-28 / Vaccine 2010 Nov;28(49):7787-96Dendritic cell vaccination of patients with metastatic colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
/in Colorectal Cancer, Hyperthermia, International Publications /von 2010-01-01 / Int J Hyperthermia 2010;26(2):108-17Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-08-08 / Med. Oncol. 2010 Sep;27(3):736-42Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer
/in Colorectal Cancer, International Publications /von 2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD006269Coordination of intratumoral immune reaction and human colorectal cancer recurrence
/in Colorectal Cancer, International Publications /von 2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-93Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
/in Colorectal Cancer, International Publications /von 2009-02-15 / Int. J. Cancer 2009 Feb;124(4):877-88
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de